Cargando…

Impact of β-blockers on survival outcomes in patients with unresectable hepatocellular carcinoma

BACKGROUND: β-blockers (BBs) have shown promise in improving overall survival (OS) in patients with breast, ovarian, pancreatic and lung cancer. However, few studies have evaluated the impact of BBs on unresectable hepatocellular carcinoma (HCC). METHODS: The authors compared clinical data and outco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altshuler, Ellery, Aryan, Mahmoud, Kallumkal, Govind, Gao, Hanzhi, Wilson, Jake, Ouni, Ahmed, De Leo, Edward, Hanayneh, Wissam, Pan, Kelsey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136628/ https://www.ncbi.nlm.nih.gov/pubmed/35665305 http://dx.doi.org/10.2217/hep-2021-0010

Ejemplares similares

Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review
por: Altshuler, Ellery, et al.
Publicado: (2022)

Highlighting Survival with Yttrium-90 Radioembolization Therapy in Unresectable Hepatocellular Carcinoma
por: Nabrinsky, Edward, et al.
Publicado: (2020)

Etiology and Management of Behavioral Disorder in Adults With Intellectual and Developmental Disabilities
por: Kallumkal, Govind H, et al.
Publicado: (2021)

Hepatocellular Carcinoma in Patients With Liver Cirrhosis Secondary to Autoimmune Hepatitis: A Case Series and Literature Review
por: Perera Mesa, Hassan, et al.
Publicado: (2022)

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Atypical Presentation of Idiopathic Retroperitoneal Fibrosis Effectively Treated With Colchicine After Lymphoma Misdiagnosis
por: Altshuler, Ellery
Publicado: (2021)

Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience
por: King, William W, et al.
Publicado: (2023)

Report of Missed Non-Hodgkin’s Lymphoma Presenting as Pathological Tibial Fracture
por: Altshuler, Ellery, et al.
Publicado: (2021)

Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma
por: Kong, Jie-Yu, et al.
Publicado: (2018)

Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma
por: Lee, Pei-Chang, et al.
Publicado: (2020)

Extragastrointestinal stromal tumors of the pelvic cavity and the vagina: Two case reports and review of the literature
por: Hanayneh, Wissam, et al.
Publicado: (2018)

Sorafenib for the treatment of unresectable hepatocellular carcinoma
por: Furuse, Junji
Publicado: (2008)

Systemic treatment for unresectable hepatocellular carcinoma
por: Leowattana, Wattana, et al.
Publicado: (2023)

Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization
por: Lanza, Ezio, et al.
Publicado: (2020)

Determinants of Survival and Post-Progression Outcomes by Sorafenib–Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma
por: Lee, I-Cheng, et al.
Publicado: (2022)

Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Primary Pulmonary Artery Sarcoma Confined to the Left Pulmonary Artery
por: Altshuler, Ellery, et al.
Publicado: (2021)

TACE-Sorafenib With Thermal Ablation Has Survival Benefits in Patients With Huge Unresectable Hepatocellular Carcinoma
por: Wu, Ying, et al.
Publicado: (2020)

Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
por: Lanza, Ezio, et al.
Publicado: (2020)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
por: Teyateeti, Ajalaya, et al.
Publicado: (2020)

Inflammation-related nomogram for predicting survival of patients with unresectable hepatocellular carcinoma received conversion therapy
por: Wu, Jia-Lin, et al.
Publicado: (2023)

Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib
por: Ko, Yi-Ling, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
por: Abd El Aziz, Mohamed A., et al.
Publicado: (2020)

Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2022)

A Primary Care Approach to Constipation in Adults with Intellectual and Developmental Disabilities
por: Mathew, Reshmi, et al.
Publicado: (2021)

Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
por: Lanza, Ezio, et al.
Publicado: (2020)

C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib
por: Tada, Toshifumi, et al.
Publicado: (2022)

Longer Survival and Preserved Liver Function after Proton Beam Therapy for Patients with Unresectable Hepatocellular Carcinoma
por: Nosaka, Takuto, et al.
Publicado: (2023)

Two Cases of Rare Pancreatic Malignancies
por: Hanayneh, Wissam, et al.
Publicado: (2019)

Y-90 Microshperes in the Treatment of Unresectable Hepatocellular Carcinoma
por: Al-Kalbani, Abdullah, et al.
Publicado: (2008)

Sorafenib Combined with Cryoablation to Treat Unresectable Hepatocellular Carcinoma
por: Ni, Hong, et al.
Publicado: (2011)

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
por: Personeni, Nicola, et al.
Publicado: (2019)

Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Tsilimigras, Diamantis I., et al.
Publicado: (2020)

Cellular based treatment modalities for unresectable hepatocellular carcinoma
por: Damiris, Konstantinos, et al.
Publicado: (2021)

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2021)

Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma
por: Kumar, Shashank, et al.
Publicado: (2023)

Dural Follicular Lymphoma: Case Report and Literature Review
por: Altshuler, Ellery, et al.
Publicado: (2021)

Synchronous Recto-Sigmoid Colorectal Carcinomas With Microsatellite Instability and an Activating PIK3CA Mutation
por: Mathavan, Mohit, et al.
Publicado: (2022)

Analysis of the Diagnosis of Burkitt-Like Lymphoma in a Patient With Atypical Cytogenetics and Molecular Markers
por: Brunner, Jackson R, et al.
Publicado: (2022)

Transarterial chemoembolization combined with Jie-du granule preparation improves the survival outcomes of patients with unresectable hepatocellular carcinoma
por: Zhao, Hetong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dmmfajv24364rfb9500cg2sp09